DOCSLIB.ORG

Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome: AUA Guideline Amendment

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome: AUA Guideline Amendment Infection/Inflammation Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome: AUA Guideline Amendment Philip M. Hanno, Deborah Erickson, Robert Moldwin* and Martha M. Faraday From the American Urological Association Education and Research, Inc., Linthicum, Maryland Purpose: The purpose of this amendment is to provide an updated clinical framework for the diagnosis and treatment of interstitial cystitis/bladder pain Abbreviations and Acronyms syndrome based upon data received since the publication of original guideline ¼ in 2011. AE adverse event Ò ¼ Materials and Methods: A systematic literature review using the MEDLINE BPS bladder pain syndrome database (search dates 1/1/83-7/22/09) was conducted to identify peer-reviewed BTX-A ¼ botulinum toxin A publications relevant to the diagnosis and treatment of IC/BPS. This initial re- CP ¼ chronic prostatitis view yielded an evidence base of 86 treatment articles after application of in- CPPS ¼ chronic pelvic pain clusion/exclusion criteria. The AUA update literature review process, in which syndrome an additional systematic review is conducted periodically to maintain guideline GTM ¼ global therapeutic currency with newly published relevant literature, was conducted in July 2013. massage This review identified an additional 31 articles, which were added to the evidence IC ¼ interstitial cystitis base of this Guideline. MPT ¼ myofascial physical Results: Newly incorporated literature describing the treatment of IC/BPS therapy was integrated into the Guideline with additional treatment information pro- Qol ¼ quality of life vided as Clinical Principles and Expert Opinions when insufficient evidence UTI ¼ urinary tract infection existed. The diagnostic portion of the Guideline remains unchanged from the original publication and is still based on Expert Opinions and Clinical Principles. Accepted for publication January 16, 2015. Conclusions: The management of IC/BPS continues to evolve as can be seen by The complete guideline is available at http:// an expanding literature on the topic. This document constitutes a clinical www.auanet.org/education/guidelines/ic-bladder- pain-syndrome.cfm. strategy and is not intended to be interpreted rigidly. The most effective This document is being prined as submitted approach for a particular patient is best determined by the individual clinician independent of editorial or peer review by the and patient. As the science relevant to IC/BPS evolves and improves, the stra- Editors of The Journal of UrologyÒ. * Financial and/or other relationship with tegies presented will require amendment to remain consistent with the highest Taris Biomedical, Urigen Pharmaceuticals and standards of care. Afferent Pharmaceuticals. For another article on a related Key Words: cystitis, interstitial; pelvic pain; urodynamics; topic see page 1676. lower urinary tract symptoms; urinary bladder diseases INTRODUCTION while minimizing adverse events THIS guideline’s purpose is to provide and patient burden. The strategies direction to clinicians and patients and approaches recommended in regarding how to recognize intersti- this document were derived from tial cystitis/bladder pain syndrome, evidence-based and consensus-based conduct a valid diagnostic process, processes. IC/BPS nomenclature is a and, approach treatment with the controversial issue; for the purpose goals of maximizing symptom con- of clarity the Panel decided to refer trol and patient quality of life to the syndrome as IC/BPS and to 0022-5347/15/1935-1545/0 http://dx.doi.org/10.1016/j.juro.2015.01.086 THE JOURNAL OF UROLOGY® Vol. 193, 1545-1553, May 2015 www.jurology.com j 1545 © 2015 by AMERICAN UROLOGICAL ASSOCIATION EDUCATION AND RESEARCH,INC. Printed in U.S.A. 1546 AUA GUIDELINE AMENDMENT consider these terms synonymous. This document construct the majority of the treatment portion of the provides an overview of the amendments made to algorithm. the 2011 Guideline and should, therefore, be viewed The initial and update reviews revealed insufficient in conjunction with the full Guideline available at publications to address IC/BPS diagnosis and overall http://www.auanet.org/education/guidelines/ic-bladder- management from an evidence basis and, therefore, the diagnosis and management portions of the algorithm pain-syndrome.cfm. The updated algorithm reflects (see figure) are provided as Clinical Principles or as these changes as well (see figure). Expert Opinion with consensus achieved using a modified Delphi technique if differences of opinion emerged.1 For a complete discussion of the methodology and evidence METHODOLOGY grading, please refer to the unabridged version of this An initial systematic review was conducted to identify Guideline. published articles relevant to the diagnosis and treatment of IC/BPS. Literature searches were performed on English language publications using the MEDLINE database from January 1, 1983 to July 22, 2009 using the BACKGROUND terms “interstitial cystitis,” “painful bladder syndrome,” Definition “bladder pain syndrome,” and “pelvic pain” as well as key The bladder disease complex includes a large group words capturing the various diagnostic procedures and of patients with bladder and/or urethral and/or treatments known to be used for these syndromes. With pelvic pain, lower urinary tract symptoms and regard to treatment, a total of 86 articles from the original literature searches met the inclusion criteria, and an sterile urine cultures, many with specific identifi- additional 31 relevant studies were retrieved as part of able causes. IC/BPS comprises a part of this com- the update literature review process. The Panel judged plex. The Panel used the IC/BPS definition agreed that these were a sufficient evidence base from which to upon by the Society of Urodynamics, Female Pelvic Interstitial cystitis/bladder pain syndrome algorithm AUA GUIDELINE AMENDMENT 1547 Medicine & Urogenital Reconstruction: “An un- it may be greatly under diagnosed in the male pleasant sensation (pain, pressure, discomfort) population.” perceived to be related to the urinary bladder, associated with lower urinary tract symptoms of Typical Course and Comorbidities more than six weeks duration, in the absence of IC/BPS is most commonly diagnosed in the fourth infection or other identifiable causes.”2 This defini- decade or after, although the diagnosis may be tion was selected because it allows treatment to delayed depending upon the index of suspicion for begin after a relatively short symptomatic period, the disease and the criteria used to diagnose it.7 A preventing treatment withholding that could occur history of a recent culture proven UTI can be iden- with definitions that require longer symptom du- tified on presentation in 18% to 36% of women, rations (i.e. six months). Definitions used in although subsequent cultures are negative.8,9 research or clinical trials should be avoided in Initially it is not uncommon for patients to report a clinical practice, as many patients may be mis- single symptom such as dysuria, frequency or pain, diagnosed or diagnosis and treatment may be with subsequent progression to multiple symp- delayed if these criteria are used.3 toms.10,11 Symptom flares, during which symptoms suddenly intensify for several hours, days or weeks, IC/BPS Symptoms are not uncommon. There is a high rate of prior pelvic Since the original publication of this Guideline, surgery (especially hysterectomy) and levator ani three papers reported data from the RICE (RAND pain in women with IC/BPS, suggesting that trauma Interstitial Cystitis Epidemiology) study.4e6 One or other local factors may contribute to symptoms.12 of the RICE study objectives was to develop an It is important to note, however, that the high IC/BPS case definition for use in epidemiological incidence of other procedures, such as hysterectomy studies that had known sensitivity and specificity. or laparoscopy, may be the result of a missed diag- Berry et al reported findings from a literature re- nosis and does not necessarily indicate that the view, a structured expert panel process and a tele- surgical procedure itself is a contributing factor to phone interview validation study to derive an symptoms. It is also common for IC/BPS to coexist IC/BPS definition.4 They note that none of the with other unexplained medical conditions, such as existing epidemiological definitions had high sensi- fibromyalgia, irritable bowel syndrome, chronic fa- tivity or high specificity. As a result of this process, tigue syndrome, Sjogren’s syndrome, chronic head- two definitions emerged, one with high sensitivity aches and vulvodynia.13,14 These associations that correctly identified IC/BPS cases 81% of the suggest that there may be a systemic dysregulation time (with 54% specificity) and one with high spec- in some patients. Finally, patients with IC/BPS ificity that correctly excluded nonIC/BPS cases frequently exhibit mental health disorders, such as 83% of the time (with 48% sensitivity). The defini- depression and anxiety. While these symptoms may tions are captured in an 11-item questionnaire. be reactive in some IC/BPS patients, there is also See the Appendix for definitions, which the Panel some evidence that there may be a common biolog- notes that these are epidemiological case definitions ical mechanism involved. and are not appropriate for use as diagnostic criteria. Conceptualizing IC/BPS Berry et al used the questionnaire to determine It is not known whether IC/BPS is a primary prevalence of IC/BPS among adult females in the bladder
Load more

Recommended publications
  • CMS Manual System Human Services (DHHS) Pub
    Department of Health & CMS Manual System Human Services (DHHS) Pub. 100-07 State Operations Centers for Medicare & Provider Certification Medicaid Services (CMS) Transmittal 8 Date: JUNE 28, 2005 NOTE: Transmittal 7, of the State Operations Manual, Pub. 100-07 dated June 27, 2005, has been rescinded and replaced with Transmittal 8, dated June 28, 2005. The word “wound” was misspelled in the Interpretive Guidance section. All other material in this instruction remains the same. SUBJECT: Revision of Appendix PP – Section 483.25(d) – Urinary Incontinence, Tags F315 and F316 I. SUMMARY OF CHANGES: Current Guidance to Surveyors is entirely replaced by the attached revision. The two tags are being combined as one, which will become F315. Tag F316 will be deleted. The regulatory text for both tags will be combined, followed by this revised guidance. NEW/REVISED MATERIAL - EFFECTIVE DATE*: June 28, 2005 IMPLEMENTATION DATE: June 28, 2005 Disclaimer for manual changes only: The revision date and transmittal number apply to the red italicized material only. Any other material was previously published and remains unchanged. However, if this revision contains a table of contents, you will receive the new/revised information only, and not the entire table of contents. II. CHANGES IN MANUAL INSTRUCTIONS: (N/A if manual not updated.) (R = REVISED, N = NEW, D = DELETED) – (Only One Per Row.) R/N/D CHAPTER/SECTION/SUBSECTION/TITLE R Appendix PP/Tag F315/Guidance to Surveyors – Urinary Incontinence D Appendix PP/Tag F316/Urinary Incontinence III. FUNDING: Medicare contractors shall implement these instructions within their current operating budgets. IV. ATTACHMENTS: Business Requirements x Manual Instruction Confidential Requirements One-Time Notification Recurring Update Notification *Unless otherwise specified, the effective date is the date of service.
    [Show full text]
  • Urinary Tract Infection (Uti) Fact Sheet
    URINARY TRACT INFECTION (UTI) FACT SHEET Overview A urinary tract infection (UTI) is an infection that involves any part of the urinary tract, including the kidneys, bladder and urethra. It is usually caused by exposure of the urinary tract to a fecal organism such as Escherichia coli (E. coli) but also may be caused by other organisms. An indwelling urinary catheter is a drainage tube that is inserted into the urinary bladder through the urethra, is left in place and is connected to a closed urine collection system. Urinary tract infections in patients with an indwelling urinary catheter are called catheter-associated UTIs, or CAUTIs. Signs and Symptoms Common symptoms of UTI include: • fever; • pain or burning in the lower abdomen; • burning during urination; • an increase in the frequency of urination; and • cloudy appearing urine. Causes and Transmission A UTI occurs when germs (usually bacteria) enter the urinary tract through the meatus (the opening of the urinary tract). These germs then cause infection. The urinary tract is normally sterile, meaning it contains no germs. A CAUTI occurs when germs (usually bacteria) enter the urinary tract through the urinary catheter and cause infection. This can occur when health care worker hands are not properly cleaned before the insertion of a catheter or during the process of cleaning or emptying of the urine collection system. Risk Factors Sexually active women, people with blockages in the urinary tract, such as prostate enlargement, and women using certain types of birth control, such as diaphragms, or those who are undergoing menopause are at higher risk of UTI.
    [Show full text]
  • A New Look at the Etiology of Interstitial Cystitis/Bladder Pain Syndrome: Extraordinary Cultivations
    International Urology and Nephrology (2019) 51:1961–1967 https://doi.org/10.1007/s11255-019-02248-5 UROLOGY - ORIGINAL PAPER A new look at the etiology of interstitial cystitis/bladder pain syndrome: extraordinary cultivations Tahsin Batuhan Aydogan1 · Oznur Gurpinar2 · Ozgen Koseoglu Eser2 · Begum Aydogan Mathyk3 · Ali Ergen1 Received: 25 April 2019 / Accepted: 24 July 2019 / Published online: 30 July 2019 © Springer Nature B.V. 2019 Abstract Purpose So far, studies have not clearly identifed infectious agents as an etiological factor for interstitial cystitis (IC). Spe- cifc microbiological diagnosis for detecting the pathogen with higher sensitivity in IC may decrease the treatment costs and increase psychosocial health of the patients. Methods A prospective clinical study was performed in 26 IC patients and 20 controls between April and September 2017. All participants were asked to give mid-stream urine sample for routine urine cultures. Followed by the negative results, symptomatic 26 patients were evaluated for L-form pathogen existence by extraordinary cultivation methods. Biopsy sam- ples were taken from 19 patients with ulcerative lesions in the bladder while collecting sterile urine samples from all 26 patients. PG broth, 5% sheep blood agar, EMB, Sabouraud’s dextrose, LEM, and GYPA were used. Followed by the 1st day inoculations, all inoculated PG broths were subcultured into the same solid media at the 2nd and 10th days in case of any growth after incubation of 24 h under 35–37 °C. The “O’Leary Sant Symptom and Problem Index” score forms were used to evaluate response to the appropriate treatment for those patients with documented pathogens.
    [Show full text]
  • Interstitial Cystitis/Painful Bladder Syndrome
    What I need to know about Interstitial Cystitis/Painful Bladder Syndrome U.S. Department of Health and Human Services National Kidney and Urologic Diseases NATIONAL INSTITUTES OF HEALTH Information Clearinghouse What I need to know about Interstitial Cystitis/Painful Bladder Syndrome U.S. Department of Health and Human Services National Kidney and Urologic Diseases NATIONAL INSTITUTES OF HEALTH Information Clearinghouse Contents What is interstitial cystitis/painful bladder syndrome (IC/PBS)? ............................................... 1 What are the signs of a bladder problem? ............ 2 What causes bladder problems? ............................ 3 Who gets IC/PBS? ................................................... 4 What tests will my doctor use for diagnosis of IC/PBS? ............................................................... 5 What treatments can help IC/PBS? ....................... 7 Points to Remember ............................................. 14 Hope through Research........................................ 15 Pronunciation Guide ............................................. 16 For More Information .......................................... 17 Acknowledgments ................................................. 18 What is interstitial cystitis/painful bladder syndrome (IC/PBS)? Interstitial cystitis*/painful bladder syndrome (IC/PBS) is one of several conditions that causes bladder pain and a need to urinate frequently and urgently. Some doctors have started using the term bladder pain syndrome (BPS) to describe this condition. Your bladder is a balloon-shaped organ where your body holds urine. When you have a bladder problem, you may notice certain signs or symptoms. *See page 16 for tips on how to say the words in bold type. 1 What are the signs of a bladder problem? Signs of bladder problems include ● Urgency. The feeling that you need to go right now! Urgency is normal if you haven’t been near a bathroom for a few hours or if you have been drinking a lot of fluids.
    [Show full text]
  • Managing Female Urethral Diverticulum with a Standardized Technique Using a Pacifier-Trick Artifice to Facilitate Dissection
    International Urogynecology Journal (2019) 30:789–794 https://doi.org/10.1007/s00192-018-3754-8 ORIGINAL ARTICLE Managing female urethral diverticulum with a standardized technique using a pacifier-trick artifice to facilitate dissection Philippe Neveü1 & Idir Ouzaid1 & Evanguelos Xylinas1 & Christophe Egrot1 & Vincent Ravery1 & Jean-François Hermieu1 Received: 21 February 2018 /Accepted: 12 August 2018 /Published online: 3 September 2018 # The International Urogynecological Association 2018 Abstract Introduction and hypothesis Managing urethral diverticula is challenging because of recurrence rate and postoperative compli- cations. Herein, we report a standardized, single-institution experience of surgical treatment of urethral diverticula in women. Methods The medical record of 37 female patients treated for urethral diverticula between 2005 and 2017 in a single institution were reviewed. All patients were operated in a standardized genupectoral position using a technical artifice called the pacifier trick to inflate diverticula throughout the procedure and facilitate its dissection. Symptoms at diagnosis, imaging findings, surgical parameters, postoperative complications, and recurrence rates were collected and are presented. Results Median age was 39 ± 11 (range 21–67) years. At diagnosis, recurrent urinary tract infections (UTI) (67%), vaginal mass (46%), pelvic pain (43%), dyspareunia (27%), and urinary incontinence (UI) (24%) were the most commonly reported symp- toms. Median operative time was 98 ± 31 (range 40–150) min. After a mean follow-up of 1 year, recurrence occurred in one (3%) patient. Immediate de novo postoperative UI decreased from 27% immediately after surgery to 3% after pelvic physical therapy. Pathological analyses found no malignant histology. Conclusions Surgical management of urethral diverticula in women is technically demanding.
    [Show full text]
  • Symptoms of Overactive Bladder and Interstitial Cystitis – How Different?
    183 Homma Y1, Tanaka M1, Niimi A1 1. Japan Red Cross Medical Centre SYMPTOMS OF OVERACTIVE BLADDER AND INTERSTITIAL CYSTITIS – HOW DIFFERENT? Hypothesis / aims of study Overactive bladder (OAB) is a symptom syndrome of urgency, frequency or urgency incontinence [1]. Interstitial cystitis (IC) is a bladder disease with a symptom syndrome of urgency, frequency, or bladder pain. Difference in symptoms of these confusable disorders is to be examined. Study design, materials and methods Female patients with OAB or IC and asymptomatic controls were recruited for the study. Diagnosis of OAB is based on 1) OAB symptom score [2] larger than 5 and/or urgency incontinence, and 2) exclusion of stress urinary incontinence and other obvious diseases. IC was diagnosed by 1) O’Leary & Sant’s symptom score [3] larger than 7 and/or bladder pain, 2) exclusion of other obvious diseases, and 3) Hunner’s ulcer or bladder bleeding at hydrodistension under anesthesia. The subjects recorded, in 3-day bladder diary, time voided, voided volume and intensity (0: none, 1: slightly, 2: moderately, 3: a lot) of 6 sensations or symptoms (urge to void, fear of leakage, amount of leakage, bladder discomfort, bladder pain and feeling of incomplete emptying) for each micturition. Additionally the urge questionnaire of 5 questions addressing the conditions during the last week was administered: 1) Did you feel urge to void that was not followed by voiding? (Response: yes, no), 2) Did you feel strong urge to void? (yes, no), 3) In case of yes in question 2, did you feel strong urge to void suddenly? (yes, no), 4) What happened or might happen, if you held strong urge to void for a long time, 1 hour for example ? (Response: leak urine, feel discomfort and/or pain, both), 5) In case of discomfort and/or pain in question 4, could you tell these 2 sensations apart? (yes, no).
    [Show full text]
  • 233 the Use of Absorbent Pads Increases the Risk For
    233 Omli R1, Skotnes L H1, Romild U1, Kuhry E1 1. Namsos Hospital THE USE OF ABSORBENT PADS INCREASES THE RISK FOR LOWER URINARY TRACT INFECTIONS IN NURSING HOMES RESIDENTS. Hypothesis / aims of study Urinary incontinence is a common medical problem in the nursing home population. The aim of this study was to determine whether use of absorbent pads is a risk factor for the development of lower urinary tract infections in nursing home residents. Introduction Lower urinary tract infections (UTIs) are a common medical problem in the elderly. Different kinds of absorbent products, such as diapers, pad and pant combinations, are used in incontinence care. In some cases, indwelling catheters, external condom catheters or in-and-out catheterisation are options for managing bladder dysfunction. About 23% of the residents in nursing homes don’t need toilet assistance. That means that the majority of residents is dependent on help from nursing staff for toileting and help to change soiled absorbent pads. Transmission of bacteria during incontinence care is associated with UTIs in elderly. In the vulnerable nursing home population, UTIs are a frequent problem and can lead to increased morbidity and even mortality. The prevalence of UTIs in nursing home residents is approximately 30%. Improving hand hygiene among staffing in nursing homes is one of the most important and effective methods to reduce hand born transmission of pathological microbes. Studies in long-term-care facilities document a lack of hand hygiene in connection to staff-resident interactions. This study studies the association between the use of absorbent pads and symptomatic UTIs in the nursing home population.
    [Show full text]
  • Module 3: Benign Prostatic Hypertrophy
    MODULE 3: BENIGN PROSTATIC HYPERTROPHY KEYWORDS: Prostatic hypertrophy, prostatic hyperplasia, PSA, voiding dysfunction, lower urinary tract symptoms (LUTS) At the end of this clerkship, the medical student will be able to: 1. Identify and name the major anatomic and histologic features of the prostate gland 2. Identify the predominant location in the prostate where BPH develops and describe how this fact relates to the symptoms and signs of BPH 3. Define BPH 4. Describe the distinctive epidemiological features and natural history of BPH 5. List the symptoms and signs of BPH 6. List the important components of the history when interviewing a patient with BPH 7. List the important components of the physical exam of a patient with BPH 8. Summarize the laboratory, radiologic, or urodynamic tests, if any, that should be ordered in a patient with BPH 9. List the indications for treatment of BPH 10. List the medical and surgical treatment options for BPH. 11. Describe when a patient with BPH should be referred to a urologist PROSTATE ANATOMY There are four basic anatomic zones of the prostate, as illustrated in Figure 1: the anterior zone, the peripheral zone, the central zone and the transition zone. Figure 1: The zones and glandular regions of the normal prostate. The anterior zone is entirely fibromuscular and non-glandular, and it appears to have little significance in prostatic function or pathology. This area comprises approximately 20% of the bulk of prostatic tissue. The peripheral zone is composed entirely of acinar tissue. It comprises the posterior surface of the prostate, including the apical, lateral, posterolateral and anterolateral portions of the prostate.
    [Show full text]
  • Urinary Incontinence ! ! !What Is Urinary Incontinence? Leakage of Urine Is Called Urinary Incontinence
    ! ! ! Urinary Incontinence ! ! !What is urinary incontinence? Leakage of urine is called urinary incontinence. Some women leak small amounts of !urine. At other times, leakage of urine is frequent or severe. !Are there different types of urinary incontinence? !There are several types of urinary incontinence: • Stress urinary incontinence is loss of urine when a woman coughs, laughs, or sneezes. Leaks also can happen when a woman walks, runs, or exercises. It is caused by a weakening of the tissues that support the bladder or the muscles of the ! urethra. • Urge incontinence is leakage of urine caused by overactive bladder muscles that ! contract too often or problems with the nerves that send signals to the bladder !• Mixed incontinence is a combination of both stress and urge incontinence symptoms • Overflow incontinence is a steady loss of small amounts of urine when the bladder does not empty all the way during voiding. It can be caused by an underactive bladder ! muscle or blockage of the urethra. !What are the symptoms of urinary incontinence? !In addition to leaking urine, a woman with incontinence also may have other symptoms: • Urgency— A strong urge to urinate whether or not the bladder is full, often with pelvic ! pressure !• Frequency— Voiding more often than she considers usual !• Nocturia — The need to void during hours of sleep !• Dysuria — Painful voiding !• Enuresis— Bed-wetting or leaking while sleeping ! What causes urinary incontinence? ! Urinary incontience can have short-term causes and long-term causes. Short-term !causes are easier to treat and include the following: • Urinary tract infection— Loss of bladder control may be caused by an infection of the urinary tract.
    [Show full text]
  • Frequently Asked Questions About Overactive Bladder
    ABOUT OAB Frequently Asked Questions about Overactive Bladder What is Overactive Bladder (OAB)? If you live with OAB, you may also: Overactive Bladder (OAB) isn’t a disease. It’s the u Leak urine (incontinence): Sometimes people name of a group of urinary symptoms. The most with OAB also have “urgency incontinence.” common symptom of OAB is a sudden urge to This means that urine leaks when you feel urinate that you can’t control. Some people will the sudden urge to go. This isn’t the same as leak urine when they feel this urge. Having to “stress urinary incontinence” or “SUI.” People urinate many times during the day and night is with SUI leak urine while sneezing, laughing or another symptom of OAB. doing other physical activities. (You can learn more about SUI at UrologyHealth.org/SUI.) How common is OAB? u Urinate frequently: You may also need to go OAB is common. It affects millions of Americans. to the bathroom many times during the day. As many as 30 percent of men and 40 percent The number of times someone urinates varies of women in the United States live with OAB from person to person. But many experts symptoms. agree that going to the bathroom more than eight times in 24 hours is “frequent urination.” Who is at risk for OAB? u Wake up at night to urinate: Waking from As you grow older, you’re at higher risk for sleep to go to the bathroom more than once a OAB. But no matter what your age, there are night is another symptom of OAB.
    [Show full text]
  • Interstitial Cystitis? You May Have Interstitial Cystitis If Any of the Following Occur: Interstitial Cystitis • You Have to Urinate Often Or Urgently
    the bladder wall. An autoimmune response (when antibodies are made that act against a part of the body such as in rheumatoid arthritis) may also be the cause in some people. How does my doctor know I have interstitial cystitis? You may have interstitial cystitis if any of the following occur: Interstitial Cystitis • You have to urinate often or urgently. • You have persistent pelvic or bladder pain. A Guide for Women • A doctor finds bladder wall inflammation, pinpoint bleed- 1. What is interstitial cystitis? ing or ulcers during an exam with a special telescope 2. What causes interstitial cystitis? (called a cystoscope) used to look inside your bladder. 3. How does my doctor know I have interstitial cystitis? • Your doctor has ruled out other diseases such as urinary 4. How is interstitial cystitis treated? tract infections, vaginal infections, bladder cancer, and sexually transmitted diseases that may mimic some of the 5. Other Treatment Options symptoms of interstitial cystitis. 6. Where can I get more information about interstitial How is interstitial cystitis treated? cystitis? Because the causes of IC are unknown, current treatments are aimed at relieving symptoms. One or a combination of treat- ments helps most people for variable periods. As researchers What is interstitial cystitis? learn more about IC the list of potential treatments will change, Interstitial cystitis (IC) is a term used to describe the condition so patients should discuss their options with a doctor. Most peo- of bladder pain or discomfort with a frequent and often urgent ple feel better after trying one or more of the following treat- need to pass urine.
    [Show full text]
  • Associated Diseases in Interstitial Cystitis/Bladder Pain Syndrome
    Associated diseases in interstitial cystitis/bladder pain syndrome Joop P. van de Merwe [email protected] Associated diseases in IC/BPS patients Table 1. Examples of associated disorders diagnosed in IC/BPS patients in comparison with Associated diseases are diseases that occur more often the general population 2,5,6 together in the same person than by chance. Associated diseases for IC/BPS (interstitial cystitis/bladder pain diagnosis prevalence (%) syndrome) include allergy, fibromyalgia, irritable bowel IC/BPS general syndrome, Crohn's disease, ulcerative colitis, systemic lupus population erythematosus, rheumatoid arthritis and Sjögren's syndrome allergy 40.6 22.5 (table 1). irritable bowel syndrome 25.4 2.9 sensitive skin 22.6 10.6 Allergy vulvodynia 10.9 15.0 An allergy occurs when a person's immune system causes an fibromyalgia 12.8 3.2 adverse reaction to substances in the environment that are chronic fatigue syndrome 7.7 8.5 harmless to most other people. These substances (so-called migraine 18.8 18.0 allergens) are found in dust mites, pets, pollen, insects, ticks, asthma 9.2 6.1 15 moulds, foods and many medications. Adverse reactions Crohn’s disease/ulcerative colitis 7.3 0.07 without involvement of the immune system are called rheumatoid arthritis 4-13 1.0 intolerance. Intolerance mainly occurs to food ingredients and systemic lupus erythematosus 1.7 0.05 drugs. Sjögren’s syndrome 8.0 0.5 People experience different symptoms, depending on the allergen, the individual's immune system, previous contact with the same allergen and where it enters the body.
    [Show full text]